======= FUT7 ======= == Gene Information == * **Official Symbol**: FUT7 * **Official Name**: fucosyltransferase 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2529|2529]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q11130|Q11130]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FUT7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUT7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602030|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a Golgi stack membrane protein that is involved in the creation of sialyl-Lewis X antigens. The encoded protein can direct the synthesis of the E-selectin-binding sialyl-Lewis X moiety. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Catalyzes alpha-1,3 glycosidic linkages involved in the expression of sialyl Lewis X antigens. {ECO:0000269|PubMed:11404359, ECO:0000269|PubMed:8207002, ECO:0000269|PubMed:9299472}. |Glyco transf 10| |leukocyte migration involved in immune response| |CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation| |regulatory T cell differentiation| |alpha-(1->3)-fucosyltransferase activity| |fucosyltransferase activity| |L-fucose catabolic process| |fucose catabolic process| |L-fucose metabolic process| |fucose metabolic process| |fucosylation| |CD4-positive, alpha-beta T cell differentiation| |CD4-positive, alpha-beta T cell activation| |alpha-beta T cell differentiation| |hexose catabolic process| |alpha-beta T cell activation| |monosaccharide catabolic process| |ceramide metabolic process| |Golgi cisterna membrane| |carbohydrate catabolic process| |T cell differentiation| |sphingolipid metabolic process| |hexose metabolic process| |monosaccharide metabolic process| |membrane lipid metabolic process| |T cell activation| |lymphocyte differentiation| |macromolecule glycosylation| |protein glycosylation| |glycosylation| |glycoprotein biosynthetic process| |leukocyte differentiation| |leukocyte migration| |lymphocyte activation| |glycoprotein metabolic process| |small molecule catabolic process| |carbohydrate metabolic process| |hemopoiesis| |hematopoietic or lymphoid organ development| |carbohydrate derivative biosynthetic process| |immune system development| |cellular amide metabolic process| |leukocyte activation| |cellular lipid metabolic process| |cell migration| |Golgi apparatus| |carbohydrate derivative metabolic process| |cell activation| |cell motility| |localization of cell| |immune effector process| |lipid metabolic process| |locomotion| |organonitrogen compound biosynthetic process| |movement of cell or subcellular component| |cellular macromolecule biosynthetic process| |small molecule metabolic process| |macromolecule biosynthetic process| |organic substance catabolic process| |immune response| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5570 * **Expression level (log2 read counts)**: -1.56 {{:chemogenomics:nalm6 dist.png?nolink |}}